200
Participants
Start Date
February 28, 2007
Primary Completion Date
July 31, 2017
Study Completion Date
July 31, 2017
TEA
Arterial feeders to tumors were identified and catheterized with a microcatheter to a branch supplying a Couinaud segment or subsegmental level for delivery of the therapeutic agent, which was Lipiodol-ethanol mixture at 2:1 ratio by volume for TEA (Lipiodol Ultrafluide, Guerbet, France; Dehydrated alcohol \[absolute alcohol\], Martindale Pharmaceuticals, United Kingdom). The agents were delivered under fluoroscopic control to completely fill up the vasculature of all tumors. The maximum total volume of Lipiodol-ethanol mixture or cisplatin emulsion to be delivered in one treatment session was 60 mL.
Department of Clinicl Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinsese University of Hong Kong, Hong Kong
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong
OTHER
Chinese University of Hong Kong
OTHER